New Horizons in Dialysis access are we Stuck with Dialysis access Options that we Know Today?: Peritoneal Dialysis: Emerging Therapies

Abstract

Get full access to this article

View all access options for this article.

References

De Vriese

A.S.D.

, Mortier

, Lameire

N.H.

. What happens to the peritoneal membrane in long-term peritoneal dialysis. Perit Dial Int 2001; 21(Suppl 3): S9–18.

Vardhan

, Zweers

M.M.

, Gokal

, Kreidet

R.T.

. A solutions portfolio approach in peritoneal dialysis. Kidney Int 2003; 64(Suppl 88): S114–23.

Witowski

, Wisniewska

, Korybalska

Prolonged exposure to glucose degradation products impairs viability and function of human peritoneal mesothelial cells.

J Am Soc Nephrol 2001; 12: 2434–41.

Wolfson

, Ogrinc

, Mujais

. Review of clinical trial experience with icodextrin. Kidney Int 2002; 62(Suppl 81): S46–52.

Young

G.A.

, Kopple

J.D.

, Lindholm

Nutritional assessment of continuous ambulatory peritoneal dialysis. An international study.

Am J Kidney Dis 1991; 17: 462–71.

Lopez

E.G.

, Lindholm

, Tranaeus

. Biocompatibility of new peritoneal dialysis solutions: Clinical experience. Perit Dial Int 2000; 20(Suppl 5): S48–56.

Pecoits-Filho

, Tranaeus

, Lindholm

. Clinical trial experiences with physioneal. Kidney Int 2003; 64(Suppl 88): S100–4.

Mortier

, Faict

, Schalkwijk

C.G.

, Lameire

N.H.

, Vriese

A.S.D.

. Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane. Kidney Int 2004, 66: 1257–65.

Williams

J.D.

, Topley

, Craig

K.J.

The Euro-Balance trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on peritoneal membrane.

Kidney Int 2004; 66: 408–18.